![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MBio Diagnostics, BARDA Team Up on Five-Minute COVID-19 Antibody Test
MBio Diagnostics, BARDA Team Up on Five-Minute COVID-19 Antibody Test
![team up](https://www.fdanews.com/ext/resources/test/Device_Images5/team-up-text.gif?t=1590011221&width=430)
MBio Diagnostics and HHS’ Biomedical Advanced Research and Development Authority (BARDA) have struck a public-private partnership to develop a COVID-19 antibody test designed to take only five minutes.
The test uses whole blood samples to detect anti-SARS-CoV-2 antibodies from active or past infections. The cartridge-based tests can be used in nonprofessional settings, such as a drive-thru clinic or walk-up testing site.
The blood test will detect both immunoglobulin M (IgM) antibodies — the first antibodies the body makes when it fights a new infection — and immunoglobulin G (IgG) antibodies, which show up later.
Upcoming Events
-
21Oct